IRVING, Texas, Nov. 20, 2017 /PRNewswire/ -- Caris Life Sciences®, a leading innovator in molecular science focusedon fulfilling the promise of precision medicine, announced today that David D. Halbert, Chairman and Chief Executive Officer, and David Spetzler, M.S., Ph.D., M.B.A., President and Chief Scientific
About Caris Life Sciences®
Caris Life Sciences® is a leading innovator in molecular science focused on fulfilling the promise of precision medicine through quality and innovation, and the world's leading immunotherapy diagnostic expert. Caris Molecular Intelligence®, the company's Comprehensive Genomic Profiling Plus (CGP+) molecular testing service, assesses DNA, RNA and proteins, including microsatellite instability (MSI), total mutational load (TML) and PD-L1, to reveal a molecular blueprint to guide more precise and personalized treatment decisions. The ADAPT Biotargeting System™, the company's revolutionary and unbiased profiling platform, is currently being utilized for drug target identification, therapeutic discovery and development, fixed tissue-based companion diagnostics, blood-based cancer screening and biomarker identification. Headquartered in Irving, Texas, Caris Life Sciences offers services throughout the U.S., Europe and other international markets. To learn more, please visit www.CarisLifeSciences.com.
Media Inquiries: The Ruth Group Kirsten Thomas / Joanna Zimmerman Tel: +1-508-280-6592 / +1-646-536-7006 firstname.lastname@example.org
View original content:http://www.prnewswire.com/news-releases/caris-life-sciences-to-present-at-the-29th-annual-piper-jaffray-healthcare-conference-300558580.html
SOURCE Caris Life Sciences
Subscribe to our Free Newsletters!
Dental Anxiety is kind of dental phobia where a person has a fear of going to dentist mainly due to ...
Kleine Levin (KLS) or sleeping beauty syndrome is a rare neurological disorder that primarly ...
LADA or Latent Autoimmune Diabetes of Adulthood is a form of type 1 autoimmune diabetes that can be ...View All